Daniell Richard 4

What Happened

• Daniell Richard, EVP, Europe Commercial at Teva (TEVA), sold a total of 91,345 shares in open‑market transactions on March 4, 2026, generating approximately $2.98 million in proceeds. The sales were executed at weighted‑average prices reported in the filing (individual sales at $32.46 and $32.95; price ranges reported $32.095–$33.30 and $32.905–$33.07).
• The filing also shows conversion/exercise entries for vested derivative awards (restricted share units) and a new grant: a 33,424‑share RSU award was recorded on March 4, 2026. Footnotes indicate the insider sold vested RSUs (including shares sold to cover tax withholding).

Key Details

• Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (no late filing indicated).
• Sales: 33,512 shares @ weighted avg $32.46 (proceeds $1,087,950); 20,461 shares @ weighted avg $32.46 (proceeds $664,256); 37,372 shares @ weighted avg $32.95 (proceeds $1,231,310). Total proceeds ≈ $2,983,516.
• Other entries: exercise/conversion (derivative) entries for 33,512 and 20,461 shares (conversion price reported as $0 in the filing — indicates conversion of RSUs to shares, not a cash purchase) and a grant (A) of 33,424 RSUs on March 4, 2026.
• Notable footnotes: trades were effected under a Rule 10b5‑1 trading plan adopted Nov 10, 2025 (F3); the insider sold vested RSUs including shares to cover tax withholding (F4); weighted‑average prices cover multiple sale lots with price ranges disclosed (F5, F6).
• Shares owned after the transactions are not shown in the excerpt provided.

Context

• The filing shows a common pattern where vested RSUs are converted to shares (derivative exercise/conversion) and then sold, including portions sold to cover taxes. The $0.00 price entries reflect conversion of RSUs rather than a cash purchase price.
• Sales by executives can be routine (compensation vesting, tax withholding, or pre‑planned 10b5‑1 sales) and do not necessarily indicate a change in personal view of the company. Purchases generally carry clearer bullish signals than routine sales.